ABM Respiratory Care’s Cough Therapy Device Cleared by FDA

April 3, 2020

The FDA has granted 510(k) clearance for ABM Respiratory Care’s BiWaze non-invasive cough therapy device.

The system is designed for patients with spinal cord injury, neuromuscular deficits or severe fatigue from intrinsic lung disease who cannot cough or clear secretions effectively.

The touchscreen device removes secretions from a patient’s upper airways and can be programmed for personalized therapy.

View today's stories